secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001740797-23-000035
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trend Innovations hires Paul Averill as COO with $600K stock salary, up to $1.2M on uplist
--------------------------------------------------------------------------------

- Paul Averill appointed COO effective April 27, 2023; base salary $600K/yr in shares, increasing to $1.2M upon Nasdaq uplisting.
- Shares paid quarterly at $150K/quarter based on 20-day VWAP; one-time $150K cash payment after equity raise.
- Employment term expires May 1, 2024; either party can terminate with 30 days' notice.
- Shares issued under Section 4(a)(2) exemption as unregistered securities to accredited investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079723000035/0001740797-23-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079723000035/tren8k_averill.htm
  HTML page:      https://secwatch.observer/filing/0001740797-23-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer